{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,22]],"date-time":"2026-01-22T06:26:15Z","timestamp":1769063175566,"version":"3.49.0"},"reference-count":23,"publisher":"Oxford University Press (OUP)","issue":"10","license":[{"start":{"date-parts":[[2006,11,1]],"date-time":"2006-11-01T00:00:00Z","timestamp":1162339200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/journals\/pages\/open_access\/funder_policies\/chorus\/standard_publication_model"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2006,11,1]]},"abstract":"<jats:title>Abstract<\/jats:title>\n               <jats:p>Radiation recall dermatitis (RRD) is an inflammatory skin reaction that occurs in a previously irradiated body part following drug administration. This phenomenon may occur from days to years following exposure to ionizing radiation. The case of a 54-year-old Caucasian woman who was initially treated with external-beam radiation to the right thoracic region following the diagnosis of a poorly differentiated squamous cell carcinoma of the right lung is reported. She received four cycles of consolidated chemotherapy with docetaxel and carboplatin. Four months later, she was admitted to the hospital for acute cholecystitis and was placed on cefotetan. She developed a tender, erythematous rash on the posterior region of her right thorax 48 hours later. The drug was withdrawn, supportive care was instituted, and the patient subsequently improved. RRD should be suspected in patients who develop an erythematous rash in a previously irradiated region. To our knowledge this entity has not been associated with cefotetan previously.<\/jats:p>","DOI":"10.1634\/theoncologist.11-10-1118","type":"journal-article","created":{"date-parts":[[2006,11,16]],"date-time":"2006-11-16T21:33:35Z","timestamp":1163712815000},"page":"1118-1120","source":"Crossref","is-referenced-by-count":14,"title":["Radiation Recall Dermatitis with Cefotetan: A Case Study"],"prefix":"10.1093","volume":"11","author":[{"given":"Ayodele","family":"Ayoola","sequence":"first","affiliation":[{"name":"a Department of Medicine, Franklin Square Hospital Center, Baltimore, Maryland, USA"},{"name":"b Department of Medicine, Hematology & Oncology Section, Harbor Hospital Center, Baltimore, Maryland, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Young Joo","family":"Lee","sequence":"additional","affiliation":[{"name":"b Department of Medicine, Hematology & Oncology Section, Harbor Hospital Center, Baltimore, Maryland, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"286","published-online":{"date-parts":[[2006,11,1]]},"reference":[{"key":"2021122208444676100_R1","doi-asserted-by":"crossref","first-page":"627","DOI":"10.1111\/j.1365-4632.2004.02406.x","article-title":"Radiation recall dermatitis","volume":"43","author":"Ristic","year":"2004","journal-title":"Int J Dermatol"},{"key":"2021122208444676100_R2","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1148\/73.2.175","article-title":"Potentiation of x-ray effects by actinomycin D","volume":"73","author":"D\u2019Angio","year":"1959","journal-title":"Radiology"},{"key":"2021122208444676100_R3","doi-asserted-by":"crossref","first-page":"1069","DOI":"10.1002\/1097-0142(19950915)76:6<1069::AID-CNCR2820760623>3.0.CO;2-7","article-title":"Radiation recall dermatitis and pneumonitis in a patient treated with paclitaxel","volume":"76","author":"Schweitzer","year":"1995","journal-title":"Cancer"},{"key":"2021122208444676100_R4","doi-asserted-by":"crossref","first-page":"698","DOI":"10.1016\/S0959-8049(96)00461-3","article-title":"Radiation-recall dermatitis with docetaxel: establishment of a requisite radiation threshold","volume":"33","author":"Yeo","year":"1997","journal-title":"Eur J Cancer"},{"key":"2021122208444676100_R5","first-page":"272","article-title":"Docetaxel-induced radiations recall dermatitis and successful rechallenge without recurrence","volume":"12","author":"Camidge","year":"2000","journal-title":"Clin Oncol (R Coll Radiol)"},{"key":"2021122208444676100_R6","doi-asserted-by":"crossref","first-page":"955","DOI":"10.1080\/028418699432653","article-title":"Radiationrecall\u2014another call with tamoxifen","volume":"38","author":"Bostrom","year":"1999","journal-title":"Acta Oncol"},{"key":"2021122208444676100_R7","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1016\/S0936-6555(05)80545-X","article-title":"Radiation reaction recall following simvastatin therapy: a new observation","volume":"7","author":"Abadir","year":"1995","journal-title":"Clin Oncol (R Coll Radiol)"},{"key":"2021122208444676100_R8","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1200\/JCO.2002.20.1.355","article-title":"Radiation recall dermatitis from high-dose interferon alfa-2b","volume":"20","author":"Thomas","year":"2002","journal-title":"J Clin Oncol"},{"key":"2021122208444676100_R9","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1007\/BF00202177","article-title":"Radiation recall in a patient with breast cancer treated for tuberculosis","volume":"48","author":"Extermann","year":"1995","journal-title":"Eur J Clin Pharmacol"},{"key":"2021122208444676100_R10","doi-asserted-by":"crossref","first-page":"452","DOI":"10.1111\/j.1365-2230.1993.tb02249.x","article-title":"Ultraviolet recall associated with etoposide and cyclophosphamide therapy","volume":"18","author":"Williams","year":"1993","journal-title":"Clin Exp Dermatol"},{"key":"2021122208444676100_R11","doi-asserted-by":"crossref","first-page":"394","DOI":"10.1016\/S0360-3016(02)02773-6","article-title":"Gemcitabine-induced radiation recall","volume":"53","author":"Jeter","year":"2002","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"2021122208444676100_R12","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1006\/gyno.1995.1139","article-title":"Radiation recall reaction to idarubicin resulting in vaginal necrosis","volume":"57","author":"Gabel","year":"1995","journal-title":"Gynecol Oncol"},{"key":"2021122208444676100_R13","doi-asserted-by":"crossref","first-page":"544","DOI":"10.1542\/peds.24.4.544","article-title":"The effect of actinomycin D on cancer in childhood","volume":"24","author":"Tan","year":"1959","journal-title":"Pediatrics"},{"key":"2021122208444676100_R14","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1007\/BF00194596","article-title":"Skin reactions induced by trimetrexate, an analog of methotrexate","volume":"4","author":"Weiss","year":"1986","journal-title":"Invest New Drugs"},{"key":"2021122208444676100_R15","doi-asserted-by":"crossref","first-page":"695","DOI":"10.1200\/JCO.2000.18.3.695","article-title":"Side effects of chemotherapy. Case 2. Radiation recall reactions induced by gemcitabine","volume":"18","author":"Castellano","year":"2000","journal-title":"J Clin Oncol"},{"key":"2021122208444676100_R16","doi-asserted-by":"crossref","first-page":"1322","DOI":"10.1002\/1097-0142(19930215)71:4<1322::AID-CNCR2820710425>3.0.CO;2-Z","article-title":"Radiation recall skin toxicity with bleomycin in a patient with Kaposi sarcoma related to acquired immune deficiency syndrome","volume":"71","author":"Stelzer","year":"1993","journal-title":"Cancer"},{"key":"2021122208444676100_R17","doi-asserted-by":"crossref","first-page":"931","DOI":"10.1001\/jama.1978.03280370027018","article-title":"Adriamycin-induced recall phenomenon 15 years after radiotherapy","volume":"239","author":"Burdon","year":"1978","journal-title":"JAMA"},{"key":"2021122208444676100_R18","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1016\/S0167-8140(01)00328-0","article-title":"Characterizing the phenomenon of radiation recall dermatitis","volume":"59","author":"Camidge","year":"2001","journal-title":"Radiother Oncol"},{"key":"2021122208444676100_R19","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1016\/j.ctrv.2005.07.008","article-title":"Radiation recall: a well recognized but neglected phenomenon","volume":"31","author":"Azria","year":"2005","journal-title":"Cancer Treat Rev"},{"key":"2021122208444676100_R20","first-page":"79","article-title":"Photo recall effect in association with cefazolin","volume":"73","author":"Garza","year":"2004","journal-title":"Cutis"},{"key":"2021122208444676100_R21","doi-asserted-by":"crossref","first-page":"1045","DOI":"10.1067\/mjd.2001.113457","article-title":"Ultraviolet recall-like phenomenon occurring after piperacillin, tobramycin and ciprofloxacin therapy","volume":"44","author":"Krishnan","year":"2001","journal-title":"J Am Acad Dermatol"},{"key":"2021122208444676100_R22","doi-asserted-by":"crossref","first-page":"4130","DOI":"10.1200\/JCO.2002.99.148","article-title":"Radiation recall dermatitis may represent the Koebner phenomenon","volume":"20","author":"Camidge","year":"2002","journal-title":"J Clin Oncol"},{"key":"2021122208444676100_R23","doi-asserted-by":"crossref","first-page":"407","DOI":"10.7326\/0003-4819-81-3-407","article-title":"Letter: Adriamycin activating a recall phenomenon after radiation therapy","volume":"81","author":"Donaldson","year":"1974","journal-title":"Ann Intern Med"}],"container-title":["The Oncologist"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1634\/theoncologist.11-10-1118","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/full-xml\/10.1634\/theoncologist.11-10-1118","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/academic.oup.com\/oncolo\/article-pdf\/11\/10\/1118\/41851525\/oncolo_11_10_1118.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/oncolo\/article-pdf\/11\/10\/1118\/41851525\/oncolo_11_10_1118.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,12,22]],"date-time":"2021-12-22T15:19:40Z","timestamp":1640186380000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/oncolo\/article\/11\/10\/1118\/6395654"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2006,11,1]]},"references-count":23,"journal-issue":{"issue":"10","published-online":{"date-parts":[[2006,11,1]]},"published-print":{"date-parts":[[2006,11,1]]}},"URL":"https:\/\/doi.org\/10.1634\/theoncologist.11-10-1118","relation":{},"ISSN":["1083-7159","1549-490X"],"issn-type":[{"value":"1083-7159","type":"print"},{"value":"1549-490X","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2006,11,1]]},"published":{"date-parts":[[2006,11,1]]}}}